Tissue Diagnostics Market Analysis By Top Key Players - Abbott Laboratories, F.Hoffmann-LA Roche Ltd

BRUSSELS - Sept. 6, 2022 - PRLog -- A tissue diagnosis is the diagnosis made when a piece of tissue is inspected by a pathologist, to analyze diseases based on tissues from organs and tumors.

The Tissue Diagnostics Market is expected to grow at a rate of ~7% by 2026. The rising prevalence of cancer and neoplastic cases, increasing demand for personalized medicines, evolving infrastructure for cancer diagnosis, technological advancement in tissue diagnostics, rising developments in consumables & instruments used in tissue diagnosis, and increasing demand for oncology screening are some of the key variables driving the worldwide tissue diagnostics market.

Mounting Adoption of Tissue Diagnostics for Early Detection & Screening of Cancer
Tissue-based diagnostic testing continues to serve as one of the gold standards for cancer diagnosis. No other technology can capture the disease's biological context and the critical parameters that factor into patient outcomes. From a biopsy, a pathologist can decide the kind of cancer, the stage, and the degree to which cancer has invaded healthy tissue. Tissue diagnosis is viewed as a productive strategy for the clinical diagnosis of these diseases. The increased adoption of tissue diagnosis to understand the causes of cancer, identify targets for treatments, and discover biomarkers is expected to boost its tissue diagnostics market interest in the coming years.

Explore Premium Report on Tissue Diagnostics Market @ https://meditechinsights.com/tissue-diagnostics-market/

Technological Advancements in Digital Pathology Fuels the Demand for Tissue Diagnostics Market
Digital pathology can help reduce human error as well as produce precise diagnostic results in a short turnaround time. The processes involved in digital pathology allow to speed up routine tasks without decreasing the quality of the execution of each task.

For instance,

• In June 2022, Roche announced the launch of its next-generation VENTANA DP 600 slide scanner. This slide scanner produces excellent image quality of stained histology slides from patient tissue samples
• In May 2022, Leica Biosystems announced the launch of its compact, dual-retort tissue processor, the HistoCore PEGASUS Plus

Competitive Landscape Analysis of Tissue Diagnostics Market
Some of the key players operating in the global tissue diagnostics market include Abbott Laboratories, F.Hoffmann-LA Roche Ltd, Danaher, Thermo Fisher Scientific, Agilent Technologies Inc., and Merck KGaA, among others.

For More Comprehensive Insights, Contact Us @ https://meditechinsights.com/contact-us/